Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA

Laura Audí, Cristina Esteban, Antonio Carrascosa, Rosa Espadero, Annalisa Pérez-Arroyo, Rosa Arjona, María Clemente, Hartmut Wollmann, Linda Fryklund, Luis A. Parodi, J. Ajram, A. Aragones, A. Arroyos, A. Balaguer, M. J. Ballester, J. Bel, M. V. Borrás, J. Bosch, N. Cabrinety, M. CaimaríM. Camprubí, P. Cantero, R. Cañete, G. Cao, G. Carreras, R. Corripio, A. De Ureta, C. J. De Valle, R. Espigares, A. Feliu, C. Fernández, J. Ferragut, A. Ferrández, A. Ferrer, M. E. Gallego, A. Gómez, J. P. González, R. Gracia, G. Grau, M. Gussinyé, P. Gutierrez, M. T. Herráez, L. Ibáñez, J. I. Labarta, J. L. Lechuga, G. Lledó, A. Llusà, R. López, J. P. López-Siguero, L. Lorenzo, C. Luzuriaga, A. Mainou, M. V. Marcos, M. J. Martínez-Aedo, P. Martul, E. Mayayo, A. Montesdeoca, R. Nosas, A. Oliver, M. J. Pisonero, N. Pons, J. M. Rial, I. Rica, S. Rite, J. Rodrigo, F. Rodríguez Hierro, A. Rodríguez, I. Rodríguez, A. Romo, J. Sánchez Del Pozo, E. Sastre, B. Sinués, B. Sobradillo, J. Tacons, A. Vela, E. Vicens-Calvet

Research output: Contribution to journalArticleResearchpeer-review

59 Citations (Scopus)

Abstract

Context: A polymorphism in the human GH receptor gene (d3/fl-GHR) resulting in genomic deletion of exon 3 has been associated with the degree of height increase in response to GH therapy. Objective: The objective of the study was to evaluate the frequencies of d3/fl-GHR polymorphism genotypes in control and short small-for-gestational-age (SGA) populations. Design: An adult control population with heights normally distributed (ACPNH) between -2 and +2 SD score (SDS) and a short non-GH-deficient SGA child population were selected. Setting: Thirty Spanish hospitals participated in the selection of the short non-GH-deficient SGA children in the setting of a controlled, randomized trial, and one of these hospitals selected the ACPNH. Controls and Patients: Two hundred eighty-nine adult subjects of both sexes constituted the ACPNH and 247 children and adolescents of both sexes the short SGA patients. Main Outcome Measures: Heights and weights were recorded in the ACPNH, and auxologic and biochemical data were recorded at each hospital for the SGA patients; d3/fl-GHR genotypes were determined and data analyzed in a single hospital. Results: In short SGA patients, d3/fl-GHR genotype frequencies were significantly different from those in ACPNH, with a higher frequency of fl/fl genotype (P < 0.0001). In ACPNH, a trend toward diminished d3/d3 genotype frequency was observed in the shortest height group (height ≤-1 SDS and ≥-2 SDS, n = 60). Conclusions: Our data showed significant differences in the frequency distribution of the d3/fl-GHR genotypes between a normally distributed adult height population and short SGA children, with the biologically less active fl/fl genotype being almost twice as frequent in SGA patients. These data suggest that the d3/fl-GHR polymorphism might be considered among the factors that contribute to the phenotypic expression of growth. Copyright © 2006 by The Endocrine Society.
Original languageEnglish
Pages (from-to)5038-5043
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number12
DOIs
Publication statusPublished - 1 Jan 2006

Fingerprint

Dive into the research topics of 'Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA'. Together they form a unique fingerprint.

Cite this